Cargando…
Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
BACKGROUND: Abnormal tuftelin 1 (TUFT1) has been reported in multiple cancers and exhibits oncogenic roles in tumor progression. However, limited data are available on the relationship between TUFT1 and hepatocellular carcinoma (HCC), and the exact biological mechanism of TUFT1 is still poorly under...
Autores principales: | Wu, Meng-Na, Zheng, Wen-Jie, Ye, Wen-Xin, Wang, Li, Chen, Ying, Yang, Jie, Yao, Deng-Fu, Yao, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218352/ https://www.ncbi.nlm.nih.gov/pubmed/34163115 http://dx.doi.org/10.3748/wjg.v27.i23.3327 |
Ejemplares similares
-
Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation
por: Zhu, Lei, et al.
Publicado: (2022) -
Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
por: Deng, Zhe, et al.
Publicado: (2021) -
Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
por: Fang, Miao, et al.
Publicado: (2020) -
Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis
por: Gu, Juan-Juan, et al.
Publicado: (2017) -
Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes
por: Zheng, Wen-Jie, et al.
Publicado: (2018)